# Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA

> **NCT00585364** · — · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 79 (actual)

## Conditions studied

- Cystic Fibrosis
- Allergic Bronchopulmonary Aspergillosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00585364
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2016-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00585364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00585364, "Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00585364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*